Bank of Nova Scotia
HZNP

Bank of Nova Scotia’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bank of Nova Scotia’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-297,009
Closed -$34.4M – 1114
2023
Q3 		$34.4M Sell
297,009
-235,491
-44% -$25.3M 0.09% 173
2023
Q2 		$54.8M Sell
532,500
-369,810
-41% -$39M 0.14% 114
2023
Q1 		$98.5M Buy
902,310
+684,167
+314% +$75.6M 0.29% 63
2022
Q4 		$24.8M Sell
218,143
-1,380,115
-86% -$115M 0.06% 207
2022
Q3 		$98.9M Buy
1,598,258
+1,092,981
+216% +$76.4M 0.31% 53
2022
Q2 		$40.3M Buy
505,277
+124,076
+33% +$11.7M 0.1% 182
2022
Q1 		$40.1M Buy
381,201
+156,663
+70% +$15.3M 0.07% 232
2021
Q4 		$24.2M Buy
224,538
+127,484
+131% +$13.9M 0.03% 349
2021
Q3 		$10.6M Buy
+97,054
New +$10.1M 0.02% 464

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Nova Scotia's HZNP Position: Q4 2023 in Review

Bank of Nova Scotia sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 297,009 shares — an estimated $34.4M sold.

Bank of Nova Scotia first reported a position in HZNP in Q3 2021 and held it in 9 quarters. The position peaked at $98.9M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Bank of Nova Scotia reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 297,009 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $34.4M.
  • Bank of Nova Scotia first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 9 quarters.
  • Bank of Nova Scotia's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $98.9M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Bank of Nova Scotia's 13F filing for Q4 2023, filed 12 Feb 2024.